The Weekly Roundup: December 2-6

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Dermatology Conferences and Meetings Calendar 2024: December

Dermatology Times asked our readers to share what conferences they are looking forward to in the fourth quarter of 2024.

Cacao Powder Shows Promise in Rejuvenating Aging Skin

A clinical trial and laboratory study assessed skin’s hydration, antioxidation, and wrinkle presence after treatment with cacao.

Acne Treatment Insights From SDPA Fall

Read more about acne treatment tips shared at the 2024 SDPA Fall Conference by experts such as Shanna Miranti, MPAS, PA-C, and Hilary Baldwin, MD.

Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsA

If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.

Regenerative Medicine Proves to Be Effective for Vitiligo Treatment

Regenerative methods such as cell therapy and platelet-rich plasma showed promising results in patient repigmentation.

Delgocitinib Reduces Inflammation and Restores Skin Barrier in CHE as a Topical Pan-JAK Inhibitor

Treatment with delgocitinib led to a significant decrease in the expression of inflammatory markers that were elevated in severe cases compared with mild cases at baseline.

Clinical Characteristics and Management of Late-Onset Vitiligo

LOV has unique clinical traits, epidemiology, and treatment responses compared to early-onset vitiligo, underscoring the need for a tailored management approach.

Reviewing Key Clinician Insights and Innovations in Vitiligo Care This Year

Explore key insights and innovations in vitiligo from 2024, from treatment advances to patient-focused strategies.

Apogee Announces Clinical Trial Advancements in APG777 for AD Treatment

Promising new data was released along with a timeline of upcoming studies evaluating potential combination therapies for atopic dermatitis.

ICYMI: FDA Greenlights Yesintek, Sixth Biosimilar to Stelara, for Psoriasis and Psoriatic Arthritis

The FDA recently approved Yesintek for treating psoriasis, psoriatic arthritis, and IBD, with a 2025 launch expected.

Comparing Effectiveness of Risankizumab and Deucravacitinib in Plaque Psoriasis

Researchers found patients treated with risankizumab had higher rates of skin clearance and greater improvement than those treated with deucravacitinib.

Dermatology Times Hosts Inaugural Horizons in Advanced Practice Meeting

The exclusive event brought together physician assistants and nurse practitioners from across the country to review atopic dermatitis and psoriasis patient cases.

Adverse Events from Apremilast Contribute to Provider Burden, New Survey Reveals

Diarrhea, nausea, and headache were the most frequently reported adverse events in psoriasis patients.

Exploring Diagnostic Accuracy and Clinical Reasoning of Dermatological Lesions in Podiatry Students

Investigating podiatry students' diagnostic accuracy and reasoning for dermatological lesions across skin tones using a mixed-method research approach.

Meta-Analysis Finds Upadacitinib to Be Most Effective for AD-Related Pruritus

Although all observed treatments showed efficacy, the 30 mg dosage of upadacitinib was most successful in relieving itch for atopic dermatitis patients.

Efficacy and Cost-Effectiveness of Integrating Dermatologists into Primary Care

Researchers found integrating dermatologists into primary care reduces costs and improves diagnostic precision for skin conditions.

Navigating Challenges and Inspiring Advocacy: A Pre-Med Student's Journey With HS

Dena Antowan shares her journey balancing pre-med life, managing HS, advocating on TikTok, and her vision for empathetic dermatologic care.

Novel AI Model Can Accurately Diagnose Onychomycosis

The algorithm demonstrated 81% accuracy, promising fast, reliable, and reproducible assessments for patients.

Plasma Protein Analysis Identifies New Drug Targets for Atopic Dermatitis

A study using proteome-wide association techniques identified novel protein biomarkers for atopic dermatitis.

Efficacy of Combining Postbiotic Formulation with Microneedling for Acne

Researchers stated that therapy represents a “valuable nonpharmacological intervention that offers an innovative therapeutic alternative” for acne treatment.

Patient-Reported Outcomes and Treatment Switching in Plaque Psoriasis

Researchers found patients reporting greater disease burden and lower HRQoL are more likely to switch to biologic therapies, regardless of clinician-rated disease severity.

Dermoscopy Can Accurately Predict Treatment Success of Cryotherapy

Certain dermoscopic features in cutaneous warts may be associated with a favorable cryotherapy response.